Auxulin Pharmaceuticals is a pharmaceutical company seeking to augment traditional insulin therapy used in the treatment of diabetes. It is engaged in the development of a clinically validated supplement (AUX-101) reducing hyperglycemic periods and hemoglobin A1C levels in patients with diabetes.